Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy.

Branger N, Pignot G, Lannes F, Koskas Y, Toledano H, Thomassin-Piana J, Giusiano S, Alessandrini M, Rossi D, Walz J, Bastide C.

World J Urol. 2019 Sep 27. doi: 10.1007/s00345-019-02965-7. [Epub ahead of print]

PMID:
31560121
2.

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.

Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22.

PMID:
23296120
3.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.

PMID:
30342844
4.

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

Walz J, Bladou F, Rousseau B, Laroche J, Salem N, Gravis G, Briganti A, Chun FK, Karakiewicz PI, Fournier G.

Urology. 2012 Mar;79(3):546-51. doi: 10.1016/j.urology.2011.11.036.

PMID:
22386393
5.

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A.

Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12.

PMID:
28412062
6.

Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data.

Rousseau C, Rousseau T, Mathieu C, Lacoste J, Potiron E, Aillet G, Nevoux P, Le Coguic G, Campion L, Kraeber-Bodéré F.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1849-56. doi: 10.1007/s00259-016-3397-2. Epub 2016 May 11.

PMID:
27164901
7.

Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.

Grivas N, Wit E, Tillier C, van Muilekom E, Pos F, Winter A, van der Poel H.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2213-2226. doi: 10.1007/s00259-017-3788-z. Epub 2017 Aug 5.

PMID:
28780722
8.

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F.

Eur Urol. 2012 Mar;61(3):480-7. doi: 10.1016/j.eururo.2011.10.044. Epub 2011 Nov 7.

PMID:
22078338
9.

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.

Briganti A, Abdollah F, Nini A, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni NM, Salonia A, Colombo R, Freschi M, Rigatti P, Montorsi F.

Eur Urol. 2012 Jun;61(6):1132-8. doi: 10.1016/j.eururo.2011.11.008. Epub 2011 Nov 12.

PMID:
22099610
10.

Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.

Porpiglia F, Manfredi M, Mele F, Bertolo R, Bollito E, Gned D, De Pascale A, Russo F, Passera R, Fiori C, De Luca S.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):85-91. doi: 10.1038/s41391-017-0026-5. Epub 2018 Feb 22.

11.

External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.

Hansen J, Rink M, Bianchi M, Kluth LA, Tian Z, Ahyai SA, Shariat SF, Briganti A, Steuber T, Fisch M, Graefen M, Karakiewicz PI, Chun FK.

Prostate. 2013 Jan;73(2):211-8. doi: 10.1002/pros.22559. Epub 2012 Jul 20.

PMID:
22821742
12.

First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.

Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI.

BJU Int. 2018 Apr;121(4):592-599. doi: 10.1111/bju.14074. Epub 2017 Nov 29.

13.

Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool.

Briganti A, Capitanio U, Abdollah F, Gallina A, Suardi N, Bianchi M, Tutolo M, Salonia A, Freschi M, Rigatti P, Montorsi F.

Prostate. 2012 Apr;72(5):499-506.

PMID:
22468270
14.

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.

Leyh-Bannurah SR, Budäus L, Zaffuto E, Pompe RS, Bandini M, Briganti A, Montorsi F, Schiffmann J, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI.

Urol Oncol. 2018 Feb;36(2):81.e17-81.e24. doi: 10.1016/j.urolonc.2017.10.022. Epub 2017 Dec 14.

PMID:
29248430
15.

External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.

Dell'Oglio P, Abdollah F, Suardi N, Gallina A, Cucchiara V, Vizziello D, Zaffuto E, Cantiello F, Damiano R, Shariat S, Montorsi F, Briganti A.

J Endourol. 2014 Apr;28(4):416-23. doi: 10.1089/end.2013.0571. Epub 2014 Jan 9.

PMID:
24188052
16.

Sensitivity and specificity of Briganti nomogram in Turkish patients undergoing radical prostatectomy and pelvic lymph node dissection.

Sahin A, Urkmez A, Yildirim C, Ali Kutluhan M, Topaktaş R, Verit A.

Aging Male. 2019 Apr 29:1-5. doi: 10.1080/13685538.2019.1601176. [Epub ahead of print]

PMID:
31033371
17.

Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A.

BJU Int. 2015 Sep;116(3):366-72. doi: 10.1111/bju.12912. Epub 2015 Jan 21.

18.

Updated Nomogram Incorporating Percentage of Positive Cores to Predict Probability of Lymph Node Invasion in Prostate Cancer Patients Undergoing Sentinel Lymph Node Dissection.

Winter A, Kneib T, Wasylow C, Reinhardt L, Henke RP, Engels S, Gerullis H, Wawroschek F.

J Cancer. 2017 Aug 22;8(14):2692-2698. doi: 10.7150/jca.20409. eCollection 2017.

19.

Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.

Gandaglia G, Zaffuto E, Fossati N, Bandini M, Suardi N, Mazzone E, Dell'Oglio P, Stabile A, Freschi M, Montorsi F, Briganti A.

BJU Int. 2018 Mar;121(3):421-427. doi: 10.1111/bju.14066. Epub 2017 Nov 27.

20.

Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.

Abdollah F, Klett DE, Sammon JD, Dalela D, Sood A, Hsu L, Diaz M, Gupta N, Peabody JO, Trinh QD, Menon M.

Can J Urol. 2016 Feb;23(1):8141-50.

PMID:
26892054

Supplemental Content

Support Center